Eun Jae Jang

Title: Innovations of Eun Jae Jang in Drug-Eluting Stents

Introduction

Eun Jae Jang is a prominent inventor based in Gwangju, South Korea. He has made significant contributions to the field of medical devices, particularly in the development of drug-eluting stents. With a total of seven patents to his name, Jang's work focuses on enhancing the efficacy and safety of stents used in coronary interventions.

Latest Patents

One of Jang's latest patents is a non-polymeric tacrolimus drug-eluting stent and its manufacturing method. This innovative method allows for a strong and stable binding of tacrolimus drug onto a stent without the need for a separate step to introduce surface-binding functional groups. The resulting stent exhibits a greater total drug elution amount and improved delayed drug-elution properties. Another notable patent is the method of manufacturing a polymer-free everolimus-eluting coronary stent fabricated by an electrospinning technique. This approach enables precise control over the drug content and forms a uniform layer without using polymers that may cause late thrombosis.

Career Highlights

Eun Jae Jang has worked with esteemed institutions such as Chonnam National University and Jeonnam Technopark. His experience in these organizations has allowed him to advance his research and development efforts in the field of medical technology.

Collaborations

Jang has collaborated with notable colleagues, including Dae Sung Park and So Youn Lee. Their combined expertise has contributed to the successful development of innovative medical devices.

Conclusion

Eun Jae Jang's contributions to the field of drug-eluting stents demonstrate his commitment to improving patient outcomes through innovative medical technology. His patents reflect a deep understanding of the complexities involved in stent design and drug delivery systems.